mammary fibroadenoma

Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Axilary mammary fibroadenoma Axilary mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma Mammary fibroadenoma

Definition: Benign breast lesion that result from hyperplasia of the normal lobules. Circumscribed, often large, breast mass usually occuring in adolescent females with stromal and epithelial hypercellularity but lacking the leaf-like growth pattern of phyllodes tumors.

Synopsis

- Common
- Benign
- Usually aged 20–35 years
- Multiple in 20%: in same breast or bilaterally
- Increase in size during pregnancy
- Tend to regress as patient ages

Pathogenesis

- Appears to be benign neoplasm of specialized stroma of breast with accompanying epithelial component
- Rapidly growing fibroadenomas in immunosuppressed individuals contain Epstein–Barr virus
- No differences between fibroadenomas removed from patients taking oral contraceptives and those in controls except occasional formation of acini in former

Gross Pathology

- sharply demarcated
- firm
- <3 cm diameter
- Cut surface: solid, grayish white, bulging
- whorl-like pattern
- slit-like spaces
- No necrosis

Histopathology

- Appearance varies and depends on: relative amount and configuration of glandular tissue; relative amount of connective tissue
- slightly hypercellular stroma but not to a degree that would justify a diagnosis of phylloides tumor.
- intracanalicular (a misnomer) when connective tissue invaginates into glandular spaces and appears to be within them
- pericanalicular when regular glandular configuration of glands maintained
- often both types in same lesion
- distinction has no practical connotations

- Tubule cells:
- cuboidal or low columnar
- round uniform nuclei
- rest on myoepithelial cell layer

- Stroma:
- usually loose connective tissue rich in acid mucopolysaccharides
- may be partially or totally dense fibrous type
- spindle cells:
- predominantly CD34-positive fibroblasts
- admixed with scattered FXIIIa-positive dendrophages4,5
- no elastic tissue
- consistent with presumed terminal duct–lobular unit (TDLU) origin of lesion
- cellularity varies from case to case:
- if unduly hypercellular consider alternative diagnosis phylloides tumor

Special Stains and Immunohistochemistry

- progesterone receptors: almost universal
- estrogen receptors: ≈25% of cases

Predisposition

If multiple and highly myxoid may be component of Carney complex, which includes:
- endocrine hyperactivity
- cardiac myxoma
- cutaneous hyperpigmentation
- other abnormalities
- other breast abnormalities:
- lobular and nodular myxoid changes26
- ductal adenoma with tubular features

Differential Diagnosis

- mammary phylloides tumor

Genetics

- ≈20% have clonal chromosome aberrations in stromal component

Prognosis

- Low long-term risk for breast carcinoma: increased risk if:

  • complex
  • ductal hyperplasia
  • family history of breast carcinoma

- not increased risk if foci of atypical epithelial hyperplasia

- Malignant changes in 0.1% of cases:

  • usually epithelial component
  • most in situ (low-grade intraductal carcinoma)
  • +/- entirely within confines of fibroadenoma
  • +/- involves surrounding breast
  • +/- may represent extension into fibroadenoma by carcinoma
  • +/- originating elsewhere in breast

- sarcomatous transformation of stroma even rarer

Differential diagnosis: mammary biphasic lesions

- adenomyoepithelioma
- mammary fibroadenomas

  • mammary juvenile fibroadenoma

- mammary hamartoma
- metaplastic mammary carcinoma
- phyllodes tumor
- pleomorphic adenoma
- gynecomastia
- pubertal macromastia

See also

- mammary tumors

References

- Wang ZC, Buraimoh A, Iglehart JD, Richardson AL. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays. Breast Cancer Res Treat. 2006 Jun;97(3):301-9. PMID: 16791486

- Fletcher JA, Pinkus GS, Weidner N, Morton CC. Lineage-restricted clonality in biphasic solid tumors. Am J Pathol. 1991;138:1199–1207.

- Kleer CG, Tseng MD, Gutsch DE, Rochford RA, Wu Z, Joynt LK, et al. Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts. Mod Pathol. 2002;15:759–764.

- Fechner RE. Fibroadenomas in patients receiving oral contraceptives. A clinical and pathologic study. Am J Clin Pathol. 1970;53:857–864.

4 - fibroadenomas and spindle cell lesions of the breast. Histopathology. 2001;38:62–67.

- Silverman JS, Tamsen A. Mammary fibroadenoma and some phylloides tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages. Histopathology. 1996;29:411–419.

- Berean K, Tron VA, Churg A, Clement PB. Mammary fibroadenoma with multinucleated stromal giant cells. Am J Surg Pathol. 1986;10:823–827.

- Goodman ZD, Taxy JB. Fibroadenomas of the breast with prominent smooth muscle. Am J Surg Pathol. 1981;5:99–101.

- Oberman HA, Nosanchuk HS, Finger JE. Periductal stromal tumors of breast with adipose metaplasia. Arch Surg. 1969;98:384–387.

- Shimizu T, Ebihara Y, Serizawa H, Toyoda M, Hirota T. Histopathological study of stromal smooth muscle cells in fibroadenoma of the breast. Pathol Int. 1996;46:442–449.

- Arrigoni MG, Dockerty MB, Judd ES. The identification and treatment of mammary hamartoma. Surg Gynecol Obstet. 1971;133:577–582.

- Metcalf JS, Ellis B. Choristoma of the breast. Hum Pathol. 1985;16:739–740.

- Petrik PK. Mammary hamartoma. Am J Surg Pathol. 1987;11:234–235.

- Azzopardi JG. Problems in breast pathology. Bennington JL editors. In: Major problems in pathology. vol. 11:Philadelphia: W.B. Saunders; 1979.

- Eusebi V, Azzopardi JG. Lobular endocrine neoplasia in fibroadenoma of the breast. Histopathology. 1980;4:413–428.

- Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD, Rados MS, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994;331:10–15.

- Kuijper A, Mommers EC, van der Wall E, van Diest PJ. Histopathology of fibroadenomas of the breast. Am J Clin Pathol. 2001;115:736–742.

- O’Hara MF, Page DL. Adenomas of the breast and ectopic breast under lactational influences. Hum Pathol. 1985;16:707–712.

- Dehner LP, Hill DA, Deschryver K. Pathology of the breast in children, adolescents, and young adults. Semin Diagn Pathol. 1999;16:235–247.

- Mies C, Rosen PP. Juvenile fibroadenoma with atypical epithelial hyperplasia. Am J Surg Pathol. 1987;11:184–190.

- Pike AM, Oberman HA. Juvenile (cellular) adenofibromas. A clinicopathologic study. Am J Surg Pathol. 1985;9:730–736.

- Fekete P, Petrek J, Majmudar B, Someren A, Sandberg W. Fibroadenomas with stromal cellularity. A clinicopathologic study of 21 patients. Arch Pathol Lab Med. 1987;111:427–432.

- Carstens PHB. Ultrastructure of human fibroadenoma. Arch Pathol. 1974;98:23–32.

- Yeh I-T, Francis DJ, Orenstein JM, Silverberg SG. Ultrastructure of cystosarcoma phylloides and fibroadenoma. A comparative study. Am J Clin Pathol. 1985;84:131–136.

- Reddick RL, Shin TK, Sawhney D, Siegal GP. Stromal proliferations of the breast. An ultrastructural and immunohistochemical evaluation of cystosarcoma phylloides, juvenile fibroadenoma, and fibroadenoma. Hum Pathol. 1987;18:45–49.

- Umekita Y, Yoshida H. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phylloides tumour: comparison with fibroadenoma. Virchows Arch. 1998;433:311–314.

- Carney JA, Toorkey BC. Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol. 1991;15:713–721.

- Petersson C, Pandis N, Rizou H, Mertens F, Dietrich CU, Adeyinka A, et al. Karyotypic abnormalities in fibroadenomas of the breast. Int J Cancer. 1997;70:282–286.

- Carter BA, Page DL, Schuyler P, Parl FF, Simpson JF, Jensen RA, et al. No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. Cancer. 2001;92:30–36.

- Buzanowski-Konakry K, Harrison EG, Payne WS. Lobular carcinoma arising in fibroadenoma of the breast. Cancer. 1975;35:450–456.

- Goldman RC, Friedman NB. Carcinoma of the breast arising in fibroadenomas with emphasis on lobular carcinoma. A clinicopathologic study. Cancer. 1969;23:544–550.

- McDivitt RW, Stewart FW, Farrow JH. Breast carcinoma arising in solitary fibroadenomas. Surg Gynecol Obstet. 1967;125:572–576.

- Diaz NM, Palmer JO, McDivitt RW. Carcinoma arising within fibroadenomas of the breast. A clinicopathologic study of 105 patients. Am J Clin Pathol. 1991;95:614–622.

- Fondo EY, Rosen PP, Fracchia AA, Urban JA. The problem of carcinoma developing in a fibroadenoma. Recent experience at Memorial Hospital. Cancer. 1979;43:563–567.

- Pick PW, Iossifides IA. Occurrence of breast carcinoma within a fibroadenoma. A review. Arch Pathol Lab Med. 1984;108:590–594.

- Curran RC, Dodge OG. Sarcoma of breast, with particular reference to its origin from fibroadenoma. J Clin Pathol. 1962;15:1–16.

[ Return to site page ]